CTRI/2017/10/010038
Completed
Phase 4
A multi-centric, randomised, comparative, clinical study for evaluation of herbal capsule in patients suffering from hemorrhoids - HILO
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Health Condition 1: K649- Unspecified hemorrhoids
- Sponsor
- Zuventus Healthcare Limited
- Enrollment
- 200
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Patients of either gender, aged \>\=18 years, with hemorrhoids confirmed by proctoscopy
- •2\.Patients able to give signed informed consent before examination.
Exclusion Criteria
- •1\.Hypersensitivity to any of the ingredients of the formulation
- •2\.Patients currently using other antihemorrhoidal drugs or planning to undergo any surgical procedure for hemorrhoids
- •3\.Pregnant women, or lactating mothers
- •4\.Patients otherwise judged to be inappropriate for inclusion in the study by the investigator
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
A clinical trial to study the effects of two drugs, Lafutidine and Rabeprazole in the Treatment of heartburn-dominant uninvestigated dyspepsia.CTRI/2009/091/000913Zuventus Healthcare Ltd202
Completed
Not Applicable
A phase III clinical trial for the two months safety and efficacy evaluation of Ostem™ (autologous cultured osteoblasts) in patients with fractureong bone fractureInjury, Occupational Diseases, PoisoningFractureISRCTN10637905Individual sponsor (South Korea)77
Completed
Phase 3
A multicentric, randomized, comparative clinical trial of Armodafinil versus Modafinil in patients with excessive sleepiness associated with shift work sleep disorder (SWSD).CTRI/2009/091/000617Emcure Pharmaceuticals Ltd Pune.
Completed
Not Applicable
Clinical study on Honey in Healthy VolunteersCTRI/2018/12/016613Dabur India Limited113
Completed
Phase 3
Efficacy and Safety of Dexketoprofen extended release tablet in the Treatment of OsteoarthritisCTRI/2009/091/000932Emcure Pharmaceuticals Ltd, Pune